09:56 AM EST, 11/06/2025 (MT Newswires) -- Collegium Pharmaceutical's ( COLL ) shares were up more than 9% in recent Thursday trading after the company reported Q3 adjusted earnings and net product revenue above analyst estimates.

The company reported Q3 adjusted earnings of $2.25 per diluted share, up from $1.61 a year earlier.

Four analysts polled by FactSet expected $1.86.

Net product revenue for the quarter ended Sept. 30 was $209.4 million, up from $159.3 million a year earlier.

Analysts surveyed by FactSet expected $189.1 million.

For 2025, the company raised its net product revenue guidance to a range of $775 million to $785 million, compared with the previous outlook of $745 million to $760 million. Analysts polled by FactSet expect $751.6 million.

Price: 39.31, Change: +3.46, Percent Change: +9.65